Intended for healthcare professionals


Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study

BMJ 2004; 329 doi: (Published 18 November 2004) Cite this as: BMJ 2004;329:1209
  1. William D-C Man ({at}, MRC clinical research fellow1,
  2. Michael I Polkey, consultant physician in respiratory medicine3,
  3. Nora Donaldson, senior lecturer in statistics2,
  4. Barry J Gray, consultant physician in respiratory medicine2,
  5. John Moxham, professor of respiratory medicine1
  1. 1 Respiratory Muscle Laboratory, Guy's, King's, and St Thomas' School of Medicine, King's College Hospital, London SE5 9PJ
  2. 2 King's College Hospital, London SE5 9RS
  3. 3 Royal Brompton Hospital, London SW3 6NP
  1. Correspondence to: W D-C Man
  • Accepted 7 September 2004


Objective To evaluate the effects of an early community based pulmonary rehabilitation programme after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease (COPD).

Design A single centre, randomised controlled trial.

Setting An inner city, secondary and tertiary care hospital in London.

Participants 42 patients admitted with an acute exacerbation of COPD.

Intervention An eight week, pulmonary rehabilitation programme for outpatients, started within 10 days of hospital discharge, or usual care.

Main outcome measures Incremental shuttle walk distance, disease specific health status (St George's respiratory questionnaire, SGRQ; chronic respiratory questionnaire, CRQ) and generic health status (medical outcomes short form 36 questionnaire, SF-36) at three months after hospital discharge.

Results Early pulmonary rehabilitation, compared with usual care, led to significant improvements in median incremental shuttle walk distance (60 metres, 95% confidence interval 26.6 metres to 93.4 metres, P = 0.0002), mean SGRQ total score (−12.7, −5.0 to −20.3, P = 0.002), all four domains of the CRQ (dyspnoea 5.5, 2.0 to 9.0, P = 0.003; fatigue 5.3, 1.9 to 8.8, P = 0.004; emotion 8.7, 2.4 to 15.0, P = 0.008; and mastery 7.5, 4.2 to 10.7, P < 0.001) and the mental component score of the SF-36 (20.1, 3.3 to 36.8, P = 0.02). Improvements in the physical component score of the SF-36 did not reach significance (10.6, −0.3 to 21.6, P = 0.057).

Conclusion Early pulmonary rehabilitation after admission to hospital for acute exacerbations of COPD is safe and leads to statistically and clinically significant improvements in exercise capacity and health status at three months.


Admissions to hospital for acute exacerbations of chronic obstructive pulmonary disease (COPD) are a massive burden to the NHS. Over the past decade, such admissions have increased by 50%, and annual hospital costs for COPD in the United Kingdom amount to more than £587m ($1.05bn;€850m).1 Exacerbations are also associated with impaired quality of life, reduced exercise capacity, and increased risk of readmission.2 Interventions designed to hasten recovery and improve symptoms after admission to hospital may lead not only to reduced use of health care in the future (and subsequent economic benefits to the NHS) but also to real improvements in quality of life and functional ability in breathless and vulnerable patients with COPD.

Pulmonary rehabilitation is a multidisciplinary programme of care for patients with chronic respiratory impairment that is individually tailored and designed to optimise each patient's physical and social performance and autonomy. Pulmonary rehabilitation leads to statistically significant and clinically meaningful improvements in health related quality of life, functional exercise capacity, and maximum exercise capacity in patients with stable COPD.3 4 Consequently, the recent guidelines on the management of COPD published by the National Institute for Clinical Excellence (NICE) and the British Thoracic Society recommend that pulmonary rehabilitation should be made available to all appropriate patients.5 However, the effects of early pulmonary rehabilitation of outpatients in the acute recovery phase after hospital admission for acute exacerbations of COPD have not previously been studied. Patients are particularly vulnerable after a hospital admission, and we assumed that early pulmonary rehabilitation of outpatients would lead to notable improvements in exercise capacity and health status, as it does in stable patients with COPD.

We assessed the feasibility and safety of an early pulmonary rehabilitation programme for outpatients and determined the effects on exercise capacity and quality of life, compared with usual care, at three months after a hospital admission for acute exacerbation of COPD.



We recruited 42 patients admitted to King's College Hospital in London with a primary diagnosis of acute exacerbation of COPD. All were deemed sufficiently unwell by the duty medical registrar to warrant admission to hospital. Exclusion criteria included comorbidity that could limit exercise training. In addition, to allow for a suitable washout period, we also excluded patients who had attended a pulmonary rehabilitation programme in the preceding year. All patients gave written informed consent.


All admitted patients received standard treatment, including nebulised bronchodilators, oxygen, oral or intravenous antibiotics, non-invasive ventilation (if required), and a one to two week course of oral prednisolone (30-40 mg daily). On discharge from hospital, patients were allocated to either an early pulmonary rehabilitation programme (within 10 days of hospital discharge) or usual care. Both groups of patients were discharged having optimal medical treatment, with a summary of their admission, to the care of their general practitioner and received standard follow up outpatient appointments with a pulmonary specialist. All patients received home diaries, which included a disease specific information pack.

Baseline assessment

We made baseline assessments in the 24 hours before patients were discharged from hospital and assigned to the intervention. We measured exercise capacity by the incremental shuttle walk test,6 a standardised, externally paced, corridor walking test, which is reproducible after a single practice walk. Patients are instructed to walk along a 10 metre course in time with prerecorded signals; initial walking speed is set at 0.50 metres per second, and increased each minute by 0.17 metres/second. The distance walked correlates well with maximum consumption of oxygen. The incremental shuttle walk is commonly used in pulmonary rehabilitation programmes in the United Kingdom as a functional outcome measure of maximum exercise capacity. We used the St George's respiratory questionnaire (SGRQ) and the chronic respiratory disease questionnaire (CRQ), both well validated in patients with COPD7 8 and often used outcome measures in pulmonary rehabilitation studies, to measure disease specific health status. We measured generic health status with the short form, 36 item questionnaire for medical outcomes (SF-36).9


A random number generator was our tool to assign an intervention to the first patient entering the study. We used the minimisation method to assign patients further to the intervention group, taking into account five factors: age (< 70 years or ≥ 70 years), sex, length of hospital admission (< 7 days or ≥ 7 days), incremental shuttle walk distance at discharge (< 100 metres or ≥ 100 metres), and predicted forced expiratory volume in one second (FEV1; < 30% or ≥ 30%). Table 1 shows baseline characteristics.

Table 1

Patients' characteristics on day of hospital discharge. Values are means with standard deviations unless otherwise indicated

View this table:

Pulmonary rehabilitation

A multidisciplinary team ran the pulmonary rehabilitation programme, which consisted of two classes per week for eight weeks. Patients were given a choice of three locations around the London boroughs of Lambeth and Southwark, but the classes were run by the same team with the same equipment. Each class lasted two hours, consisting of one hour of exercise (aerobic walking and cycling, strength training for the upper and lower limb) and one hour of educational activities (with an emphasis on self management of the disease, nutrition, and lifestyle issues). Respiratory physiotherapists and nurses supervised the exercise component, as did health centre based fitness instructors. Physiotherapists, respiratory nurses, an occupational therapist, a dietician, a respiratory doctor, a smoking cessation adviser, a social worker, a pharmacist, and a lay member of a patients' group supervised education activities on a rolling rota. Patients also received individualised home exercise programmes, which encouraged at least 20 minutes of exercise per day.

Assessment of outcome

We reassessed primary outcome measures (exercise capacity and disease specific and generic health status) at three months after hospital discharge. In addition, we recorded secondary outcome measures of use of hospital resources, including number of readmissions, hospital days, and visits to the accident and emergency department not requiring admission. We gathered this information principally from hospital records, corroborated by the patients' home diaries.


Owing to the nature of the intervention and financial and logistical considerations, it was not possible to blind the patients or the assessors. The assessors were either the investigator responsible for assignment or members of the pulmonary rehabilitation team who were directly or indirectly involved in the delivery of the intervention.

Sample size calculation

The primary outcome measure for the study was the incremental shuttle walk distance. On the basis of previous audit data, a sample size calculation estimated that at least 30 patients (15 in each group) would be required to show a 50 metre difference in shuttle walk distance (standardised difference 1.2) with 90% power at the 5% significance level.

Data analysis and statistical methods

We analysed data on an intention to treat basis. We made no attempt to impute “missing” data from those participants who were lost to follow up. We calculated means (standard deviations) or medians (ranges or interquartile ranges) as appropriate. We used unpaired t tests to compare mean differences between groups for SGRQ, CRQ, and SF-36 scores. Because of the highly skewed distribution we used Mann-Whitney and univariate median regressions to compare median shuttle walks between groups. We used the Mann-Whitney test to test differences between groups in hospital bed days. We used incident rate ratios and the Poisson regression for rates of hospital readmission and accident and emergency visits. We used SPSS, version 12, and Stata, version 8, for the computations.


Flow and follow up of participants

Figure 1 shows the progress of participants through the study. We initially assessed 69 patients for eligibility over a six month period. Seventeen patients were not enrolled for medical reasons or met exclusion criteria: coexisting unstable ischaemic heart disease (n = 7), pulmonary rehabilitation in preceding year (n = 4), coexisting probable or definite diagnosis of lung cancer (n = 3), chronic alcohol abuse (n = 2), and wheelchair bound owing to rheumatoid arthritis (n = 1). Ten patients refused consent: “felt too ill” (n = 4), “clash with other social activities” (n = 3), “no likely benefit to me” (n = 3). Of the 42 patients recruited, three month exercise capacity and health status data were not available for eight patients because they died (n = 3), were lost to follow up because they had moved abroad or out of area (n = 2), developed serious comorbidity unrelated to COPD (n = 2), and withdrew because of allocation to usual care (n = 1). The mean attendance rate at the pulmonary rehabilitation class was 73%, with 6 of the 18 patients attending less than 50% of the classes. No adverse events were reported in the early rehabilitation group. Table 2 shows baseline and three month data in the usual care and early pulmonary rehabilitation groups.

Table 2

Baseline and three month data. Data are mean scores (SD) and differences between groups were compared by using unpaired t tests unless otherwise indicated

View this table:

Flow of participants through the study

Exercise capacity, the SGRQ impacts and total score, all four domains of the CRQ, and the mental component score of the SF-36 in favour of early pulmonary rehabilitation improved significantly. The magnitude of these mean improvements greatly exceeded the recognised minimal clinically important differences for these measures. In addition, the rehabilitation group made far fewer visits to accident and emergency departments, and we saw a trend towards reduced hospital readmission rate and fewer hospital days.


Attendance at a community based pulmonary rehabilitation programme shortly after a hospital admission for an acute exacerbation of COPD leads to clinically important improvements in exercise capacity and health status at three months. Furthermore, the number of attendances at the accident and emergency department was lower and hospital admission was required in fewer cases.

Comparison with other studies

Excellent evidence supports the benefits of pulmonary rehabilitation in stable patients with COPD.3 4 This study examines the effects of this outpatient intervention in patients during the early recovery period after a hospital admission for an acute exacerbation. Despite optimal medical treatment during hospital admission, patients at discharge take considerable time to recover to baseline levels of physical functioning and health status. Previous studies have shown that up to 25% of patients after an acute exacerbation do not fully recover to baseline peak flow at three months10 and that the recovery period in health status is long even in patients who do not have further exacerbations.11 Our data indicate that patients can safely participate in a community based pulmonary rehabilitation programme for outpatients shortly after an exacerbation and that such a programme speeds up recovery from the debilitating effects of a hospital admission. Furthermore, the magnitude of the effects of early pulmonary rehabilitation on exercise capacity and health status are considerably greater than, and in addition to, the effects of bronchodilator or corticosteroid therapy.12

Limitations of the study

The study did not explore the mechanisms by which early pulmonary rehabilitation achieves its effects. Possible explanations include physiological improvements in skeletal muscle function, desensitisation to dyspnoea, and psychosocial lifestyle changes. Dysfunction of the skeletal muscles is well recognised in patients with COPD13 and is particularly marked during a hospital admission14 owing to a variety of factors, including atrophy resulting from disuse, systemic inflammatory mediators, and use of corticosteroids. A limitation of this study is that, for obvious reasons, it was not possible to blind patients to the intervention. Hence a placebo effect cannot be excluded as the principal mechanism for the improvements observed. However, it should be noted that early pulmonary rehabilitation led to considerable improvements in the distances covered in the incremental shuttle walk. The maximum distance walked during this test correlates well with peak oxygen consumption,6 hence it is likely that a true physiological training effect contributed to the improvements. The psychological effects, effects of self education about the disease, or placebo effects of pulmonary rehabilitation in an often socially isolated group of patients should not be minimised. A recent, multicentre, randomised controlled trial showed that an education programme for patients (consisting of weekly visits by a health professional for a two month period, with monthly telephone follow up) led to reduced use of healthcare resources in patients with severe COPD.15 Another limitation of the study is that the assessors were not fully blinded to treatment allocation as they may have been directly or indirectly involved in the delivery of the intervention. This introduces an element of bias to the results, but it is important to note that the SGRQ and the SF-36 questionnaires are completed by the patients themselves, without direct input from investigators, and the incremental shuttle walk and the CRQ are highly standardised outcome measures that do not place subjective requirements on the investigator.

Viability of the programme

Exercise training after an acute exacerbation of COPD is not a novel concept. Behnke et al looked at the effects of an initial, 10 day, inpatient training programme, followed by six months of supervised home training, compared with usual care, in patients admitted for an acute exacerbation of COPD.16 They showed improvements in six minute walking distance and sum scores on the questionnaire on chronic respiratory disease at three months and six months after training compared with control. However, such a programme would not be viable in terms of manpower or finance, given that inpatient stay contributes 54% of all direct healthcare costs associated with COPD in the United Kingdom.17 In contrast, a community based pulmonary rehabilitation programme for outpatients is a more realistic option. Previous data support the cost effectiveness of pulmonary rehabilitation programmes on an outpatient basis and the likelihood of financial benefit to the health service.18

Possible health economic impact and outlook

The a priori primary outcome measures were exercise capacity, as measured by the incremental shuttle walk, and health status. However, secondary outcome measures included use of hospital resources, and fewer visits were made to the accident and emergency department in the group undergoing early pulmonary rehabilitation. Patients in the treated group were readmitted 30% less often than patients in the control group, and there was a trend towards fewer hospital inpatient days. The results therefore imply that early pulmonary rehabilitation may reduce usage of healthcare resources and bring improvements in exercise capacity and health status.

What is already known on this topic

Hospital admission for acute exacerbations of chronic obstructive pulmonary disease (COPD) is an enormous financial burden to the NHS

Pulmonary rehabilitation is an effective, non-pharmacological intervention in the management of stable patients with COPD, and the recent guidelines from the National Institute for Clinical Excellence recommend that it should be made available to all patients who would benefit

What this study adds

Early pulmonary rehabilitation, in the recovery period after hospital discharge after an admission for an acute exacerbation of COPD, leads to significant improvements in functional capacity and quality of life at three months compared with usual care

Larger randomised studies are required to determine whether the benefits of early pulmonary rehabilitation translate into improved health economics. Other unanswered questions include the long term effects of early pulmonary rehabilitation, and the optimal structure, location, and duration of pulmonary rehabilitation programmes.

Despite medical optimisation during hospital admission for acute exacerbations of COPD, early pulmonary rehabilitation after discharge from hospital leads to additional notable improvements in exercise capacity and health status at three months compared with usual care.


  • Embedded Image The CONSORT checklist of items to include when reporting a randomised controlled trial is on

    We thank the Southwark and Lambeth pulmonary rehabilitation team for running and supervising the rehabilitation programme described in this work.

  • Contributors WD-CM conceived the idea of the study, obtained grant funding, designed the protocol, recruited subjects, collected and analysed data and wrote the first and final drafts of the manuscript. MIP helped design the protocol of the study, interpreted data, and helped write the first and final drafts of the manuscript. ND helped design the study, performed statistical analysis of the data and helped write the first and final drafts of the manuscript. BJG helped design the study, recruited patients, interpreted data and helped write the first and final drafts of the manuscript. JM was the senior investigator, and will act as guarantor. He helped conceive the idea and design of the study, obtained grant funding, interpreted data, and helped write the first and final drafts of the manuscript. Christine Jones and Caroline Mooney helped in the recruitment of subjects. Renata Morello, Sheena Radford, Julie Backley, Lynda Haggis, Claire Bradley, Lauren Moore, and Debbie James were involved in data collection and were members of the multidisciplinary team that provided the active intervention.

  • Funding This study was supported by a British Lung Foundation Trevor Clay Memorial Grant. WD-CM is a clinical research training fellow of the Medical Research Council (UK). The Southwark and Lambeth pulmonary rehabilitation team is in part funded by “Pursuing Perfection,” coordinated by the NHS Modernisation Agency

  • Competing interests None declared.

  • Ethical approval The local research ethics committee approved the study.


  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.
  7. 7.
  8. 8.
  9. 9.
  10. 10.
  11. 11.
  12. 12.
  13. 13.
  14. 14.
  15. 15.
  16. 16.
  17. 17.
  18. 18.
View Abstract